News | Artificial Intelligence | June 13, 2019

Company to showcase its newest artificial intelligence software solution at the SIFEM Medical Conference in France

iCAD Introduces ProFound AI for 2D Mammography in Europe

June 13, 2019 — iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to iCAD’s deep-learning, artificial intelligence (AI) platform and follows the launch of ProFound AI for Digital Breast Tomosynthesis (DBT), which was CE Marked in March 2018 and U.S. Food and Drug Administration (FDA)-cleared in December 2018. ProFound AI for 2D Mammography and ProFound AI for DBT will both be featured in the iCAD exhibition booth at the Société Française d'Imagerie de la FEMme (SIFEM) medical conference June 13-15, 2019, in Lille, France.

ProFound AI is available for both mammography and tomosynthesis modalities; it is a high-performance, deep-learning, breast cancer detection and workflow solution that offers benefits to radiologists and patients alike. ProFound AI for DBT is clinically proven to improve cancer detection rates by 8 percent, reduce unnecessary patient recall rates by 7.2 percent, and slash reading time for radiologists by 52.7 percent and up to 57.4 percent for dense breast 3-D image analysis.1

“The arrival of the ProFound AI platform has completely changed the way we read tomosynthesis cases. It is a very powerful and extremely useful tool that improves our diagnostic confidence; especially for subtle lesions and dense breasts,” according to Patrick Toubiana, M.D., radiologist, president and cofounder at the C.S.E. Centre Imagerie Médicale Numérique in Paris. “In addition, ProFound AI allows us to optimize our workflow for better reading comfort and a reduction of the interpretation time of the tomosynthesis slices. Today, ProFound AI is a real asset in our daily practice that we could not do without.”

ProFound AI for 2D Mammography and ProFound AI for DBT were designed to rapidly and accurately analyze each image. They provide radiologists with key information, such as certainty of finding lesion and case scores, which assists in clinical decision-making and prioritizing caseloads. Featuring the latest in deep learning AI, the platform also allows for continuously improved performance via ongoing updates.

ProFound AI for 2D Mammography is pending CE Mark in the EU.

For more information: www.icadmed.com

Related Content

FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis

VIDEO: How iCad Uses AI to Speed Breast Tomosynthesis

 

Reference

Hoffmeister J. (2018). Artificial Intelligence for Digital Breast Tomosynthesis – Reader Study Results. [White paper]. Accessed June 4, 2019 via https://www.icadmed.com/assets/dmm253-reader-studies-results-rev-a.pdf

Related Content

News | PACS

November 24, 2021 — Konica Minolta Healthcare Americas Inc. announced new features and functionality for the Exa ...

Time November 24, 2021
arrow
News | Breast Imaging

November 24, 2021 — Hologic Inc. will showcase its extensive portfolio of breast and skeletal health products, including ...

Time November 24, 2021
arrow
News | Flat Panel Displays

November 24, 2021 — The rise of digital imaging technology has quickly changed the way in which patient data are used ...

Time November 24, 2021
arrow
News | Artificial Intelligence

November 24, 2021 — Radiologists can now register their practices to take part in the next-generation American College ...

Time November 24, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

November 24, 2021 — Royal Philips announced new AI-enabled innovations in MR imaging launching at the Radiological ...

Time November 24, 2021
arrow
News | Coronavirus (COVID-19)

November 24, 2021 — Significant decreases in CT imaging for cancer persisted even after the peak of the COVID-19 ...

Time November 24, 2021
arrow
News | Lung Imaging

November 23, 2021 — Median Technologies announces new outstanding performance of its lung cancer screening (LCS) CADx1 ...

Time November 23, 2021
arrow
News | Artificial Intelligence

November 23, 2021 — Laurel Bridge Software Inc., a provider of imaging software solutions that enables health systems to ...

Time November 23, 2021
arrow
News | Artificial Intelligence

November 23, 2021 — The results of a unique two-tiered brain tumor AI challenge were announced today by the Radiological ...

Time November 23, 2021
arrow
News | Radiology Business

November 23, 2021 — Guerbet LLC, the U.S. affiliate of Guerbet, a global leader in medical imaging, is pleased to be ...

Time November 23, 2021
arrow
Subscribe Now